Drug Type CAR-T |
Synonyms AVC 102, AVC-102, AVC102 |
Target |
Action modulators |
Mechanism PSMA modulators(Prostate-specific membrane antigen modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Cancer | Phase 2 | Germany | 23 Nov 2020 | |
| Castration-Resistant Prostatic Cancer | Clinical | Germany | 30 Jan 2022 |





